TSMCs Unstoppable Growth Drives Taiwans Stock Market to Fifth Largest Globally BlockCon Punta Cana Where Web3 iGaming and Finance Intersect at Global Business Retreat World Insurance Bolsters Florida Presence Through Lock Insurance Acquisition China Confirms Order for 200 Boeing Jets Marking First Major Purchase in Nearly a Decade Trump Escalates Conflict with Republicans Over Proposed 18bn AntiWeaponisation Fund New York Fed Study Reveals Disproportionate Impact of Rising Gas Prices on LowerIncome Households Tevogen Bio Holdings Q4 2025 Earnings NarrowerthanExpected Loss Fails to Lift Shares FLYW Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines NXE Q1 2026 Earnings EPS Misses Estimates Significantly as Stock Gains on LongTerm Outlook NATH Q4 2024 Earnings EPS of 096 Signals Resilient Profitability NTGR Q1 2026 Earnings Significant EPS Beat Signals Turnaround Progress Adagio Medical Holdings ADGM Q1 2026 Earnings WiderThanExpected Loss Highlights Ongoing Development Costs Toll Brothers TOL Gains 139 as Homebuilder Sector Finds Support Ellington Financial EFC Slips Slightly as Stock Nears Key Support Cadiz Inc Depositary Shares CDZIP Slightly Lower as Consolidation Continues Near Support Shattuck Labs STTK Holds Steady Near Support as Biotech Sector Watches Key Levels CVR Partners UAN Edges Higher as Support Holds Firm Cybersecurity Job Demand Surges 11 in Q1 as AI Era Reshapes Workforce CSPI Q1 2026 Earnings 003 EPS Amidst Uncertainty Precigen Inc PGEN Tests Key Support as Bearish Pressure Persists Near 403 Warby Parker WRBY Q1 2026 Earnings EPS Beat Drives Optimistic Start to Fiscal Year POWL Q1 2026 Earnings EPS Misses Estimates amid Operational Headwinds Shares Edge Higher STAA Q1 2026 Earnings Strong EPS Surprise of 45385 Driven by Operational Efficiency NXPI Q1 2026 Earnings EPS Beat Drives Stock Jump CIB Q4 2025 Earnings Massive Earnings Miss as EPS Plunges to 1926 vs Estimate of 20099 NEM Q1 2026 Earnings Strong EPS Beat but Shares Slide 289 NEUP Q1 2026 Earnings WiderThanExpected Loss Narrows Sharply as Clinical Pipeline Progress Drives Investor Optimism